REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA

Clinical trials for REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA trials appear

Sign up with your email to follow new studies for REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New immune therapy tested for rare HIV-Linked cancer

Disease control Ongoing

This early-stage study is testing the safety of a drug called dostarlimab for people with HIV and a rare, treatment-resistant cancer called Kaposi sarcoma. Dostarlimab is an immunotherapy designed to help the body's own immune system fight cancer cells. The study will enroll up t…

Matched conditions: REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA

Phase: PHASE1 • Sponsor: Imperial College London • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA

Get alerted when new REFRACTORY HIV ASSOCIATED KAPOSI SARCOMA trials appear

New immune therapy tested for rare HIV-Linked cancer